| Company Name: |
Shanghai Biolang biotechnology Co.,Ltd
|
| Tel: |
17764003753 |
| Email: |
2326587775@qq.com |
| Products Intro: |
Product Name:Enavogliflozin CAS:1415472-28-4 Purity:99% HPLC Package:100MG, 1G, 10G, 1KG
|
| Company Name: |
Suzhou Rovathin Foreign Trade Co.,Ltd
|
| Tel: |
0512-65816829 18662214788 |
| Email: |
info@rovathin.com.cn |
| Products Intro: |
Product Name:Enavogliflozin CAS:1415472-28-4 Package:1g;10g Remarks:(1S)-1,5-Anhydro-1-C-[7-chloro-6-[(4-cyclopropylphenyl)methyl]-2,3-dihydro-4-benzofuranyl]-D-glucitol
|
|
| | D-Glucitol, 1,5-anhydro-1-C-[7-chloro-6-[(4-cyclopropylphenyl)methyl]-2,3-dihydro-4-benzofuranyl]-, (1S)- Basic information |
| Product Name: | D-Glucitol, 1,5-anhydro-1-C-[7-chloro-6-[(4-cyclopropylphenyl)methyl]-2,3-dihydro-4-benzofuranyl]-, (1S)- | | Synonyms: | D-Glucitol, 1,5-anhydro-1-C-[7-chloro-6-[(4-cyclopropylphenyl)methyl]-2,3-dihydro-4-benzofuranyl]-, (1S)-;(2S,3R,4R,5S,6R)-2-(7-chloro-6-(4-cyclopropylbenzyl)-2,3-dihydrobenzofuran-4-yl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol;DWP-16001;Enavogliflozin(DWP-16001);agent,sodium-glucose,Enavogliflozin,inhibit,selective,SGLT,DWP 16001,orally,Inhibitor,cotransporter,Sodium-dependent glucose cotransporters,antidiabetic,DWP16001;Afacifenacin Impurity 4;Enavogliflozin, 10 mM in DMSO;Enavogliflozin | | CAS: | 1415472-28-4 | | MF: | C24H27ClO6 | | MW: | 446.92 | | EINECS: | | | Product Categories: | | | Mol File: | 1415472-28-4.mol | ![D-Glucitol, 1,5-anhydro-1-C-[7-chloro-6-[(4-cyclopropylphenyl)methyl]-2,3-dihydro-4-benzofuranyl]-, (1S)- Structure](CAS/20211123/GIF/1415472-28-4.gif) |
| | D-Glucitol, 1,5-anhydro-1-C-[7-chloro-6-[(4-cyclopropylphenyl)methyl]-2,3-dihydro-4-benzofuranyl]-, (1S)- Chemical Properties |
| Boiling point | 666.1±55.0 °C(Predicted) | | density | 1.438±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 100 mg/mL (223.75 mM; Need ultrasonic) | | form | Solid | | pka | 13.18±0.70(Predicted) | | color | White to off-white |
| | D-Glucitol, 1,5-anhydro-1-C-[7-chloro-6-[(4-cyclopropylphenyl)methyl]-2,3-dihydro-4-benzofuranyl]-, (1S)- Usage And Synthesis |
| Uses | Enavogliflozin (DWP-16001), an antidiabetic agent, is an orally active, best-in-class and selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor[1][2][3]. | | IC 50 | SGLT2 | | References | [1] Daewoong speeds up developing antidiabetic Enavogliflozin [2] These are the results of clinical trials of the diabetes drug Enavogliflozin and Metformin [3] Global Diabetes Pipeline Landscape Report 2020 Featuring Daewoong's Enavogliflozin & Janssen Biotech's Golimumab Among Others - ResearchAndMarkets.com |
| | D-Glucitol, 1,5-anhydro-1-C-[7-chloro-6-[(4-cyclopropylphenyl)methyl]-2,3-dihydro-4-benzofuranyl]-, (1S)- Preparation Products And Raw materials |
|